Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting
Tullio Palmerini(University of Bologna), Gregg W. Stone(Cardiovascular Institute of the South), Philippe Gabríel Steg(Mount Sinai Hospital), Byeong‐Keuk Kim(Yonsei University), Philippe Généreux(Morristown Medical Center), Yangsoo Jang(Yonsei University), Deepak L. Bhatt(Mount Sinai Hospital), Adnan Kastrati(Deutsches Herzzentrum München), Martine Gilard(Hôpital Maison Blanche), Alaide Chieffo, Gilles Montalescot(Maastricht University Medical Centre), Stefanie Schüpke, Antonio Colombo(Humanitas University), Marco Valgimigli(University of Bern), Alexandre Abizaid(Universidade de São Paulo), Hyo‐Soo Kim(Inje University Ilsan Paik Hospital), Myeong‐Ki Hong(Yonsei University), Jung‐Min Ahn(Ulsan College), Abdourahmane Diallo(Université Paris Cité), Mattia Romanello(University of Bologna), Giuseppe Biondi‐Zoccai(Maria Cecilia Hospital), Diego Della Riva(University of Bologna), Fausto Feres(Instituto Dante Pazzanese de Cardiologia), Maria Letizia Bacchi Reggiani, Éric Vicaut(Université Paris Cité), Yaling Han(Harbin Medical University), Bo Xu(Jiangnan University), Seung‐Jung Park(Samsung Medical Center), Gérard Helft(Sorbonne Université), Marie-Claude Morice(Institut Cardiovasculaire Paris Sud), Kyung Woo Park(Seoul National University Hospital)
Cited by 146
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k